The World Health Organisation (WHO) on Monday insisted that there was no approved vaccine in Nigeria or any part of Africa for the coronavirus disease (COVID-19).
WHO Immunisation Team Lead, Dr Fiona Braka, spoke with NAN on the efforts of the world body on the reported vaccines for the deadly virus.
Braka said researches were ongoing on the deadly viral disease.
She said COVID-19, being a new disease, has no ready vaccines, adding that public safety was the key consideration of WHO campaign for now.
“COVID-19 is a new disease, and as such, there are no ready vaccines available to be deployed for the control of the pandemic.
“However, a lot of research and scientific works are ongoing to develop vaccines, but these usually take time to ensure that it is safe for use in the wider population and also effective for control of the pandemic.
“Public safety is a key consideration in this process,” the WHO team lead said.
Braka added that the claims of vaccines developed for COVID-19 were untrue and not to the knowledge of the WHO.
“WHO is not aware of vaccine for COVID-19 in Nigeria.
“There is a large scientific study (clinical trial) involving many countries to review the effectiveness of some drugs for the treatment of COVID-19 going on at the moment.
“The result of this clinical trial will help understand the efficacy of these drugs and may inform the review of the case management guidelines,” she said.
On the assessment of Nigeria’s performance in curbing the spread of COVID-19, Braka said that the world health body partnership with the Nigeria Centre for Disease Control (NCDC) had been helpful.
“Nigerian Government through the Nigerian Centre for Disease Control (NCDC) and supported by WHO had developed a preparedness plan for COVID-19 and was implementing this plan when the first case was reported.
“A network of five COVID testing laboratories was set up before the confirmation of the first case and has since been expanded to six additional laboratories over the past two weeks, making a total of 11 laboratories currently.
“From the onset of the outbreak, WHO has developed clinical guidance with input from clinicians around the globe, including in Nigeria.
“These resources include the updated Clinical Management Guidance for COVID-19, the Clinical Care training materials, and the Global COVID-19 Clinical Data Platform, the data tool which makes it possible for WHO to collect core clinical data from hospitalised patients to inform understanding of COVID-19.
“The guidance is continually reviewed, as more evidence become available.
“The government has scaled up isolation facilities capacity at state level to ensure readiness to receive COVID patients,” she said.
